company background image
2289

Charmacy Pharmaceutical SEHK:2289 Stock Report

Last Price

HK$12.18

Market Cap

HK$1.3b

7D

7.8%

1Y

64.6%

Updated

01 Oct, 2023

Data

Company Financials

Charmacy Pharmaceutical Co., Ltd.

SEHK:2289 Stock Report

Mkt Cap: HK$1.3b

2289 Stock Overview

Charmacy Pharmaceutical Co., Ltd. engages in pharmaceutical distribution business in the People’s Republic of China.

2289 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance4/6
Financial Health4/6
Dividends2/6

Charmacy Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Charmacy Pharmaceutical
Historical stock prices
Current Share PriceHK$12.18
52 Week HighHK$20.00
52 Week LowHK$4.81
Beta-0.24
1 Month Change-12.12%
3 Month Change48.54%
1 Year Change64.59%
3 Year Change167.11%
5 Year Change45.52%
Change since IPO52.25%

Recent News & Updates

If EPS Growth Is Important To You, Charmacy Pharmaceutical (HKG:2289) Presents An Opportunity

Sep 17
If EPS Growth Is Important To You, Charmacy Pharmaceutical (HKG:2289) Presents An Opportunity

Recent updates

If EPS Growth Is Important To You, Charmacy Pharmaceutical (HKG:2289) Presents An Opportunity

Sep 17
If EPS Growth Is Important To You, Charmacy Pharmaceutical (HKG:2289) Presents An Opportunity

Is Charmacy Pharmaceutical (HKG:2289) A Risky Investment?

May 02
Is Charmacy Pharmaceutical (HKG:2289) A Risky Investment?

What Type Of Returns Would Charmacy Pharmaceutical's(HKG:2289) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

Mar 15
What Type Of Returns Would Charmacy Pharmaceutical's(HKG:2289) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

Are Dividend Investors Making A Mistake With Charmacy Pharmaceutical Co., Ltd. (HKG:2289)?

Feb 17
Are Dividend Investors Making A Mistake With Charmacy Pharmaceutical Co., Ltd. (HKG:2289)?

We Wouldn't Rely On Charmacy Pharmaceutical's (HKG:2289) Statutory Earnings As A Guide

Jan 27
We Wouldn't Rely On Charmacy Pharmaceutical's (HKG:2289) Statutory Earnings As A Guide

Returns On Capital At Charmacy Pharmaceutical (HKG:2289) Paint An Interesting Picture

Jan 09
Returns On Capital At Charmacy Pharmaceutical (HKG:2289) Paint An Interesting Picture

What Charmacy Pharmaceutical Co., Ltd.'s (HKG:2289) ROE Can Tell Us

Dec 22
What Charmacy Pharmaceutical Co., Ltd.'s (HKG:2289) ROE Can Tell Us

Reflecting on Charmacy Pharmaceutical's (HKG:2289) Share Price Returns Over The Last Three Years

Nov 29
Reflecting on Charmacy Pharmaceutical's (HKG:2289) Share Price Returns Over The Last Three Years

Shareholder Returns

2289HK HealthcareHK Market
7D7.8%0.8%-1.4%
1Y64.6%15.1%4.4%

Return vs Industry: 2289 exceeded the Hong Kong Healthcare industry which returned 15.1% over the past year.

Return vs Market: 2289 exceeded the Hong Kong Market which returned 4.4% over the past year.

Price Volatility

Is 2289's price volatile compared to industry and market?
2289 volatility
2289 Average Weekly Movement15.0%
Healthcare Industry Average Movement7.0%
Market Average Movement6.5%
10% most volatile stocks in HK Market14.1%
10% least volatile stocks in HK Market3.2%

Stable Share Price: 2289 is more volatile than 90% of Hong Kong stocks over the past 3 months, typically moving +/- 15% a week.

Volatility Over Time: 2289's weekly volatility has increased from 8% to 15% over the past year.

About the Company

FoundedEmployeesCEOWebsite
1984811Chuanglong Yaohttps://www.chmyy.com

Charmacy Pharmaceutical Co., Ltd. engages in pharmaceutical distribution business in the People’s Republic of China. The company distributes western medicines, Chinese patent medicines, healthcare products, and related consulting services to downstream distributors and retail terminals. It also operates Charmacy e-Medicine, a B2B e-commerce platform to place orders online, make inquiries and payments, etc. The company was formerly known as Chuangmei Pharmaceutical Co., Ltd.

Charmacy Pharmaceutical Co., Ltd. Fundamentals Summary

How do Charmacy Pharmaceutical's earnings and revenue compare to its market cap?
2289 fundamental statistics
Market CapHK$1.32b
Earnings (TTM)HK$103.07m
Revenue (TTM)HK$4.89b

12.8x

P/E Ratio

0.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
2289 income statement (TTM)
RevenueCN¥4.56b
Cost of RevenueCN¥4.27b
Gross ProfitCN¥285.80m
Other ExpensesCN¥189.70m
EarningsCN¥96.09m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.89
Gross Margin6.27%
Net Profit Margin2.11%
Debt/Equity Ratio118.4%

How did 2289 perform over the long term?

See historical performance and comparison

Dividends

4.0%

Current Dividend Yield

51%

Payout Ratio